These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. (-)- s -tetrahydrocannabinol: two novel in vitro metabolites. Maynard DE; Gurny O; Pitcher RG; Kierstead RW Experientia; 1971 Oct; 27(10):1154-5. PubMed ID: 5127857 [No Abstract] [Full Text] [Related]
44. Plasma cannabinoids measured by radioimmunoassay in rabbits after intravenous injection of tetrahydrocannibinol, 11-hydroxy-tetrahydrocannabinol, cannabinol and cannabidiol. Teale JD; Clough JM; Piall EM; King LJ; Marks V Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):339-42. PubMed ID: 1153879 [TBL] [Abstract][Full Text] [Related]
45. Metabolism and distribution of cannabinoids in rats after different methods of administration. Leighty EG Biochem Pharmacol; 1973 Jul; 22(13):1613-21. PubMed ID: 4729809 [No Abstract] [Full Text] [Related]
46. Tolerance and disposition of tetrahydrocannabinol in man. Hunt CA; Jones RT J Pharmacol Exp Ther; 1980 Oct; 215(1):35-44. PubMed ID: 6256518 [TBL] [Abstract][Full Text] [Related]
47. The disposition of clavulanic acid in man. Bolton GC; Allen GD; Davies BE; Filer CW; Jeffery DJ Xenobiotica; 1986 Sep; 16(9):853-63. PubMed ID: 3765664 [TBL] [Abstract][Full Text] [Related]
48. Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration. Lemberger L; Weiss JL; Watanabe AM; Galanter IM; Wyatt RJ; Cardon PV N Engl J Med; 1972 Mar; 286(13):685-8. PubMed ID: 5061055 [No Abstract] [Full Text] [Related]
49. Distribution of delta 9-tetrahydrocannabinol in the mouse. Freudenthal RI; Martin J; Wall ME Br J Pharmacol; 1972 Feb; 44(2):244-9. PubMed ID: 4668591 [TBL] [Abstract][Full Text] [Related]
50. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol. McCallum ND; Yagen B; Levy S; Mechoulam R Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243 [No Abstract] [Full Text] [Related]
51. Disposition and excretion of 14C-AHTN (7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene) and 14c-hhcb (1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-cyclopenta-gamma-2-benzopyran) after intravenous administration to Sprague-Dawley rats and domestic pigs. Api AM; Ritacco G; Sipes IG Int J Toxicol; 2013 Jul; 32(4):288-95. PubMed ID: 23685777 [TBL] [Abstract][Full Text] [Related]
52. Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat. Caldwell J; Dring LG; Williams RT Biochem J; 1972 Aug; 129(1):11-22. PubMed ID: 4646771 [TBL] [Abstract][Full Text] [Related]
53. Disposition and metabolism of darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in humans. Dave M; Nash M; Young GC; Ellens H; Magee MH; Roberts AD; Taylor MA; Greenhill RW; Boyle GW Drug Metab Dispos; 2014 Mar; 42(3):415-30. PubMed ID: 24378325 [TBL] [Abstract][Full Text] [Related]
54. Excretion of THC and its metabolites in ewes' milk. Jakubovic A; Tait RM; McGeer PL Toxicol Appl Pharmacol; 1974 Apr; 28(1):38-43. PubMed ID: 4859325 [No Abstract] [Full Text] [Related]
55. Metabolism and disposition of l-alpha-acetylmethadol in the rat. Henderson GL; North-Root H; Kuttab SH Drug Metab Dispos; 1977; 5(4):321-8. PubMed ID: 19211 [TBL] [Abstract][Full Text] [Related]